Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTROL: NovoSeven in Severely Injured Trauma Patients
NCT00184548Phase 3Terminated
- Sponsor
- Novo Nordisk
- Start
- Oct 2005
- Primary completion
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 14
01
Overview
A Phase 3 trial of coagulation factor VIIa in traumatic hemorrhage, sponsored by Novo Nordisk. Started Oct 2005; status: terminated.
02
Drugs
coagulation factor VIIa
03
Conditions
traumatic hemorrhage
Beyond the preview
Go deeper on NCT00184548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00184548.